Search results
Results from the WOW.Com Content Network
Since 15 March 2020, Strang has provided daily updates on the COVID-19 pandemic in Nova Scotia. He became Nova Scotia's public health lead communicator on matters related to the COVID-19 pandemic in Nova Scotia. In daily press conferences, he provides updates on the COVID-19 pandemic and the public health effort to respond to it. [9]
The COVID-19 pandemic in Nova Scotia is an ongoing viral pandemic of coronavirus disease 2019 , a novel infectious disease caused by severe acute respiratory syndrome coronavirus 2 . On March 15, 2020, three presumptive cases in Nova Scotia were announced.
The Nova Scotia Health Authority is a provincial health authority serving Nova Scotia, Canada. It is the largest employer in the province, with more than 23,000 employees, 2,500 physicians and 7,000 volunteers working from 45 different facilities. [ 1 ]
A CDC study published last summer found that people who got both their flu shot and COVID-19 vaccine at the same time experienced slightly more side effects — an increase of 8% to 11% — than ...
On February 10, 2021, similar circumstances in Newfoundland and Labrador prompted Nova Scotia to restrict travel from that province as well, [26] leaving the final remnant of the original Atlantic bubble in place only for travel from Prince Edward Island into Nova Scotia. Dependant on COVID-19 cases, PEI's Chief Health Office Dr. Heather ...
Queen Elizabeth II Health Sciences Centre, in Halifax, Nova Scotia, Canada, is a large teaching hospital and Level 1 Trauma Centre affiliated with Dalhousie University. The QEII cares for adult patients. Pediatric patients within the region are cared for at the IWK Health Centre. Administratively, the QEII is part of the Nova Scotia Health ...
Cape Breton Regional Hospital is a Canadian hospital in Sydney, Nova Scotia.. Operated by the Nova Scotia Health Authority, the Cape Breton Regional Hospital opened in 1995, replacing the Sydney City Hospital (opened in 1916) and St. Rita's Hospital (opened in 1920).
From early 2020 through 2021, several hundred drug companies, biotechnology firms, university research groups, and health organizations were developing therapeutic candidates for COVID-19 disease in various stages of preclinical or clinical research (506 total candidates in April 2021), with 419 potential COVID-19 drugs in clinical trials, as ...